Navigation Links
Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
Date:4/29/2009

New Screening Test Will Focus on 4.3 Million Annual U.S. Birth Market

SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN) and Entest BioMedical Inc., BMSN's wholly-owned subsidiary, today announced that a contract has been signed with Dr. Brian Koos, a professor of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA for the development, refinement, and validation of a screening test for gestational diabetes, a glucose intolerance in pregnant women. Dr. Koos is the developer of a screening test for gestational diabetes licensed to Entest BioMedical by UCLA. The screening test mitigates the lengthy process of diagnosing gestational diabetes and would allow for faster treatment of the disease. Entest is the exclusive licensee for Dr. Koos' gestational diabetes screening test. Both companies stated that their goal is to develop a large scale sampling for validation of the screening test with Food and Drug Administration. The gestational diabetes screening test would be marketed to hospitals and medical clinics. The U.S. Dept. of Health and Human Services recently reported that there are approximately 4.3 million live births in the U.S.

According to Dr. Koos, "There is a very large potential market for our screening test. Gestational diabetes is diabetes that is found for the first time when a woman is pregnant. Out of every 100 pregnant women in the U.S., three to eight get gestational diabetes. Diabetes means your blood glucose (or blood sugar) is too high. The body uses glucose for energy, but too much glucose in the blood can be harmful. An additional concern is that untreated or uncontrolled gestational diabetes can result in serious problems for your baby, such as being born very large and with extra fat. Such large infants are predisposed to birth injury and to obesity later in life. This non-invasive screening test
'/>"/>

SOURCE Bio-Matrix Scientific Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Thomson Scientific Predicts Nobel Laureates
3. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
4. Thomson Scientific Announces BONDplus for Biological Researchers
5. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
6. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
7. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
8. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
9. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
10. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
11. Delta Dental Plans Association Forms National Scientific Advisory Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... PULLMAN, Wash. - Smoking today,s concentrated pot might ... research from Washington State University. The study is ... development of tolerance to THC. , Psychology ... estrogen levels, female rats are at least 30 ... qualities of THCthe key active ingredient in cannabis. ...
(Date:9/2/2014)... 03, 2014 http://topcreatinemonohydrate.com/ , ... athletes obtain the latest information about muscle and ... which focuses mainly on testosterone and ... increase their workout capacity and improve their athletic ... Top Creatine Monohydrate, Muscle Advance Creatine is one ...
(Date:9/2/2014)... Becker's Healthcare is excited to ... Information Officer Strategy Roundtables on November 4-5, 2014 ... Review Chief Executive Officer and Chief Information Officer ... Chief Executive Officers, Chief Financial Officers, Chief Information ... executives through high-quality continuing education, networking events, and ...
(Date:9/2/2014)... Recently, BambooIndustry.com, an excellent company in the bamboo industry, ... bamboo floors to celebrate the coming of autumn. ... the frequent callers, BambooIndustry.com launched a promotion for its ... woven floors, BambooIndustry.com provides many kinds of wonderful items ... woven floors, click lock floors, wide plank floors and ...
(Date:9/2/2014)... 2, 2014 4 pm EDT): In a Viewpoint published ... Association , a team of Boston researchers call for ... quality in the United States. The researchers from the ... University, Harvard University and Boston Children,s Hospital write that ... foods could both help people make meaningful dietary changes ...
Breaking Medicine News(10 mins):Health News:Estrogen increases cannabis sensitivity 2Health News:Estrogen increases cannabis sensitivity 3Health News:Creatine Monohydrate Reviews Site TopCreatineMonohydrate.com Announces its Launch 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2
... Fla., July 6 After 25 years in the fitness ... fitness classes, Dale Buchanan, a Washington, DC native, has created ... to South Florida in his new studio located in Boca ... of High Intensity Fitness Training and T,ai Chi. , ...
... July 6 ATS Medical, Inc. (Nasdaq: ... cardiac surgery products and services, today announced FDA ... Simulus(R) Semi-Rigid Annuloplasty Band. The Simulus Semi-Rigid Annuloplasty ... Genesee BioMedical and represents the latest addition to ...
... ... blood tests at detecting lead levels in the body, , ... San Diego, CA (Vocus) July 6, 2009 -- Until now, ... , , , ,However, that has changed thanks to LeadConfirm Professional, a new saliva-based ...
... a leading online retailer of adult diapers and other ... television advertising in order to boost market share. Mr. ... reducing our traditional web marketing efforts at all; we ... broaden our branding efforts." , , The specialty ...
... have another reason to pour that extra cup. When aged ... caffeine the equivalent of five cups of coffee a ... South Florida researchers at the Florida Alzheimer,s Disease Research Center. ... of Alzheimer,s Disease , show caffeine significantly decreased abnormal levels ...
... peanuts, eggs and more , SUNDAY, July 5 (HealthDay ... desensitize children and adults to environmental allergens such as ... researchers are trying to apply that theory to food ... , They believe they can build up a child,s ...
Cached Medicine News:Health News:Boca Raton, FL Becomes Home of Dale Buchanan's Supreme Ultimate Fitness 2Health News:ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band 2Health News:ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band 3Health News:LeadConfirm Professional Now Available at Overstock.com--The First Oral Based Lead Test Makes Getting the Lead Out Easier 2Health News:LeadConfirm Professional Now Available at Overstock.com--The First Oral Based Lead Test Makes Getting the Lead Out Easier 3Health News:LeadConfirm Professional Now Available at Overstock.com--The First Oral Based Lead Test Makes Getting the Lead Out Easier 4Health News:GoldenAgeMedical.Com Announces National TV Campaign 2Health News:Caffeine reverses memory impairment in Alzheimer's mice 2Health News:Caffeine reverses memory impairment in Alzheimer's mice 3Health News:Kids May 'Learn' to Tolerate Food Allergens 2Health News:Kids May 'Learn' to Tolerate Food Allergens 3
(Date:9/2/2014)... Sept. 2, 2014 Reportlinker.com announces that ... its catalogue: BRIC Bariatric Surgery ... http://www.reportlinker.com/p02343483/BRIC-Bariatric-Surgery-Devices-Market-Outlook-to-2020.html BRIC Bariatric Surgery ... Summary GlobalData,s new report, "BRIC Bariatric ... market data on the BRIC Bariatric Surgery Devices ...
(Date:9/2/2014)... 2, 2014 Perrigo Company plc, a public limited ... (the " Company "), today announced that it is ... its new 1.30% Senior Notes due 2016 (the " 2016 ... due 2018 (the " 2018 Exchange Notes "), $800,000,000 of ... Exchange Notes ") and $400,00,000 of its new 5.30% Senior ...
(Date:9/2/2014)... , Spanien und CALGARY, Alberta ... Vorgestellt in der "State of the Art ... 2014    Resverlogix Corp. (TSX: RVX) gab ... Medical Affairs bei Resverlogix, beim Kongress des europäischen Kardiologenverbandes ... einen Vortrag gehalten hat. In seinem Vortrag mit dem ...
Breaking Medicine Technology:BRIC Bariatric Surgery Devices Market Outlook to 2020 2BRIC Bariatric Surgery Devices Market Outlook to 2020 3BRIC Bariatric Surgery Devices Market Outlook to 2020 4BRIC Bariatric Surgery Devices Market Outlook to 2020 5BRIC Bariatric Surgery Devices Market Outlook to 2020 6BRIC Bariatric Surgery Devices Market Outlook to 2020 7BRIC Bariatric Surgery Devices Market Outlook to 2020 8BRIC Bariatric Surgery Devices Market Outlook to 2020 9BRIC Bariatric Surgery Devices Market Outlook to 2020 10Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 4RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 2RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 3RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 4RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 5RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 6
... BEIJING , July 12 /PRNewswire-Asia-FirstCall/ -- Concord Medical ... CCM ), the,operator of the largest network of radiotherapy and ... as of July 1, 2010 it has entered,into ... Chang,An,Hospital,s cancer treatment facilities by acquiring a 52% equity interest ...
... , MOUNTAIN VIEW, Calif. , July 12 ... that it has selected AZ-007 ( Staccato zaleplon) for ... move forward into active development.  This decision follows an Alexza ...  In addition, Alexza has created Addicere Therapeutics, Inc., a wholly-owned ...
Cached Medicine Technology:Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 2Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 3Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 4Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 2Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 3Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 4Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 5Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 6Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 7Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 8
... The ANA and ENA assays ... patients negative for antinuclear antibodies, which ... diseases such as Systemic lupus erythematosus ... disease, progressive systemic sclerosis, scleroderma, polymyositis, ...
... Indirect Fluorescence Assay (IFA) for Anti-native ... for the qualitative and semi-quantitative detection ... nDNA in human serum. Detection of ... be used as an aid in ...
Anti-Tg and Anti-TPO are two major autoantibodies implicated in autoimmune related thyroiditis and aid in the differential diagnosis of Hashimoto's thyroiditis and Graves' disease....
... The Company's first commercial product is the ... single-use, disposable assay devices . The advantages ... are direct use of a vacuum-type blood ... result in minutes. VerifyNow IIb/IIIa, the first ...
Medicine Products: